Related Experiment Video
Updated: Aug 19, 2026

A Comparative Study of Drug Delivery Methods Targeted to the Mouse Inner Ear: Bullostomy Versus Transtympanic Injection
Published on: March 8, 2017
Practolol and deafness
Abstract:
Practolol ('Eraldin') is a beta-blocking agent whose prolonged use may result in the appearance of untoward side-effects, notably ocular symptoms, skin rashes and deafness. We report ten cases of deafness due, or thought to be due, to practolol; and in all except three of the cases (8,9 and 10), the deafness became manifest many months after the appearance of lesions in the skin and eyes. Progression of any hearing loss caused by this drug seems to be arrested by its withdrawal. Otologists are urged to report any suspicious cases to the Committee on Safety of Medicines, Finsbury Square House, 33/37A Finsbury Square, London EC2A IPP.
More Related Videos
11:39Assessment of Audio-Tactile Sensory Substitution Training in Participants with Profound Deafness Using the Event-Related Potential Technique
Published on: September 7, 2022
03:49Enhanced Cochlear Coverage and Hearing Preservation in High-Frequency Hearing Loss via Electric Acoustic Stimulation with Longer Electrode
Published on: October 11, 2024
Related Concept Videos
The Cochlea
Auditory Pathway
When viewed cross-sectionally, the cochlea reveals the scala vestibuli and scala tympani flanking the...